MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dementia"

  • 2016 International Congress

    [18F]AV-1451 PET imaging of tau in progressive supranuclear palsy and Alzheimer’s disease

    J.B. Rowe, P. Vázquez Rodríguez, Y.T. Hong, R.J. Borchert, S. Sami, W.R. Bevan-Jones, S.P. Jones, R. Arnold, A. Surendranathan, E. Mak, S. Li, T. Fryer, J. O'Brien, L. Passamonti (Cambridge, United Kingdom)

    Objective: To evaluate: (1) brain tau pathology in vivo in patients with Progressive Supranuclear Palsy (PSP) and Alzheimer's disease (AD); (2) whether brain tau pathology…
  • 2016 International Congress

    Cognitive deficits in Parkinson’s disease: A preliminary study of neuropsychological profiles

    R.J. Giannaula, P.G. Sanz, J.C. Maiques, M.B. Seijas, M.J. González Aguilar, L. Grasso (Buenos Aires, Argentina)

    Objective: The purpose of this project was to examine cognitive deficits in a patient sample fulfilling the diagnostic criteria for idiopathic non-demented Parkinson's disease (PD)…
  • 2016 International Congress

    The role of neuroinflammation in the development of Parkinson’s disease dementia

    A. Kouli, R. Vuono, R.A. Barker, C.H. Williams-Gray (Cambridge, United Kingdom)

    Objective: To evaluate, at post-mortem, the pattern and characteristics of neuroinflammatory change in Parkinson's disease (PD) brain and to assess its relationship with aberrant alpha-synuclein,…
  • 2016 International Congress

    Clinical profile of Parkinson’s disease at the neurology department of Point G Teaching Hospital

    T. Coulibaly, A.S. Sissoko, T. Coulibaly, L. Guida, K. Mamadou, G.C. Oumar (Bamako, Mali)

    Objective: To determine the frequency and clinical features of PD at the neurology department of Point G Teaching Hospital. Background: PD results from loss of…
  • 2016 International Congress

    Disruption of functional connectivity in Parkinson’s disease patients presenting phonemic fluency impairment

    K. Kawabata, H. Watanabe, E. Bagarinao, N. Yoneyama, K. Hara, R. Ohdake, K. Imai, M. Masuda, T. Yokoi, T. Tsuboi, M. Ito, N. Atsuta, M. Katsuno, G. Sobue (Nagoya, Japan)

    Objective: This study was designed to clarify the changes of detailed functional connectivity in association with phonemic fluency deficits in Parkinson's disease (PD) patients using…
  • 2016 International Congress

    Analysis of cognitive disorders of Parkinson’s disease (PD) in the comparative aspect

    S. Lukmonov, D. Tolibov, A. Sobirov, F. Yunusov, D. Jalilov, K. Abdukhalimova, A. Kalendarev (Tashkent, Uzbekistan)

    Objective: Purpose of investigation was to conduct a comparative assessment of cognitive impairment in Parkinson's disease. Background: According to modern concepts, parkinsonism - is not…
  • 2016 International Congress

    Grey matter atrophy associated with the progression of cognitive decline in Parkinson’s disease (PD)

    M. Chondrogiorgi, L.G. Astrakas, A.K. Zikou, M.I. Argyropoulou, S. Konitsiotis (Ioannina, Greece)

    Objective: To investigate the pattern of grey matter (GM) atrophy associated with cognitive decline in PD by use of voxel-based morphometry (VBM) analysis. Background: Loss…
  • 2016 International Congress

    E-counselling to movement disorder callers in Africa

    M. Busgopaul (Nouvelle France, Mauritius)

    Objective: Providing online counselling service to Movement Disorder patients. Background: This paper will deal with online counselling delivered to Movement Disorder callers. Helpline Mauritius (www.helplinemauritius.org)…
  • 2016 International Congress

    Comparative analysis of clinical and neuroimaging features of parkinsonism and dementia of Alzheimer’s type

    D. Tolibov, G. Rakhimbaeva (Tashkent, Uzbekistan)

    Objective: Explore the features of cognitive disorders and neuroimaging features of Parkinson's disease (PD) and Alzheimer's disease (AD) in the comparative aspect. Methods: Study 64…
  • 2016 International Congress

    Comparison of the utility of three cognitive scales for MDS Level-I diagnosis of mild cognitive impairment in Parkinson’s disease: MoCA, PD-CRS and ACE-III

    R. Fernandez-Bobadilla, J. Pagonabarraga, J.A. Matias-Guiu, S. Martínez-Horta, A. Horta-Barba, J. Marin-Lahoz, J. Perez-Perez, B. Pascual-Sedano, H. Bejr-Kasem, A. Campolongo, J. Kulisevsky (Barcelona, Spain)

    Objective: To compare the utility for detecting Mild Cognitive Impairment in Parkinson's disease (PD-MCI) of three abbreviated global scales: the Montreal Cognitive Assessment (MoCA), the…
  • « Previous Page
  • 1
  • …
  • 26
  • 27
  • 28
  • 29
  • 30
  • …
  • 33
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley